vismodegib
vismodegib is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including ERIVEDGE. Available dosage form: capsule.
Drug Details
- Generic Name
- vismodegib
- Brand Names
- ERIVEDGE
- Application Number
- NDA203388
- Sponsor
- Genentech, Inc.
- NDC Codes
- 1
- Dosage Forms
- CAPSULE
- Routes
- ORAL
- Active Ingredients
- VISMODEGIB
Indications and Usage
1 INDICATIONS AND USAGE ERIVEDGE is indicated for the treatment of adults with metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery and who are not candidates for radiation. ERIVEDGE ® (vismodegib) is a hedgehog pathway inhibitor indicated for the treatment of adults with metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery and who are not candidates for radiation. ( 1 )